Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis

On a global scale, renal cell carcinoma (RCC) is the second most common form of cancer and the 10th leading cause of cancer-related deaths. There are about 70% of cases of RCC that are clear cell renal cell carcinomas (ccRCCs). This study explores possible targets for immune therapy in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Lin, Liu, Xinyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101751/
https://www.ncbi.nlm.nih.gov/pubmed/37065178
http://dx.doi.org/10.1155/2023/3898610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101751/
https://www.ncbi.nlm.nih.gov/pubmed/37065178
http://dx.doi.org/10.1155/2023/3898610

Ejemplares similares